Last edition
News about "GSK CEO Emma Walmsley "
GSK to Invest USD 30 Billion in US R&D and Supply Chain Over Next 5 Years
GSK has announced plans to invest USD 30 billion across the United States over the next five years to strengthen its R&D, drug discovery, development, and clinical trial activity.
GSK CEO Emma Walmsley | 17/09/2025 | By Dineshwori
GSK Q2 Sales Hit GBP 8 Billion, Driven Mainly by Specialty Medicines
GSK has delivered robust second-quarter 2025 results, fueled primarily by strong growth in its Specialty Medicines portfolio.
GSK CEO Emma Walmsley | 31/07/2025 | By Dineshwori | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy